Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer
-
Published:2024-10
Issue:5
Volume:47
Page:100698
-
ISSN:2319-4170
-
Container-title:Biomedical Journal
-
language:en
-
Short-container-title:Biomedical Journal
Author:
Chang John Wen-Cheng,
Hsieh Jia-Juan,
Tsai Chih-Yu,
Chiu Horng-Yih,
Lin Yu-Feng,
Wu Chiao-En,
Shen Yung-Chi,
Hou Ming-Mo,
Chang Chieh-Ying,
Chen Jian-An,
Chen Chyi-Liang,
Chiu Cheng-Tang,
Yeh Yuan-Ming,
Chiu Cheng-HsunORCID
Reference41 articles.
1. The human gut microbiome - a potential controller of wellness and disease;Kho;Front Microbiol,2018
2. Repetitive transcranial direct current stimulation modulates the brain-gut-microbiome axis in obese rodents;Ziomber-Lisiak;Pharmacol Rep,2022
3. Roles of microbiota in cancer: from tumor development to treatment;Bagheri;JAMA Oncol,2022
4. Derosa L, Routy B, Enot D, Baciarello G, Massard C, Loriot Y, et al. Impact of antibiotics on outcome in patients with metastatic renal cell carcinoma treated with immune checkpoint inhibitors. J Clin Oncol 2017;35 :462(suppl).
5. Role of the microbiota in immunity and inflammation;Belkaid;Cell,2014
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献